Siddharth Malhotra, founder of Cohrtx

$36M Series A

Cohrtx

Cohrtx Raises $36M Series A for Agentic Trial Ops Across Clinical Cohorts

  • Clinical AI
  • Trial Ops
  • Life Sciences

Matter-style agents for clinical trial operations—protocol mapping, site packet chase, and deviation narratives with immutable evidence so sponsors stop losing months to manual cohort admin.

Siddharth Malhotra · Stanford dropout / ex-Epic

“If it cannot survive sponsor audit, it is a demo. Every cohort action has to leave a board-defensible trail.”

— Founder

“Copilot revenue is a feature; closed trial packets are a company. Cohrtx sells resolution, not another dashboard.”

— Hemant Taneja · General Catalyst